Zepbound is not recommended in patients with severe gastroparesis (delayed gastric emptying)
Many patients report noticeable improvements in digestion , energy levels , and overall wellness within the first few weeks of use
10.1016/j.jhep.2023.05.013 68 RosenstockJ.WyshamC.FrasJ
While traditional treatments focus on glucose and lipid control, growing evidence suggests inflammation may continue Read More GLP-1 Adherence in the Real World: Why Patients Stop and How Clinicians Can Help Mar 17, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,160 views Staying consistent with GLP-1 therapy remains one of the biggest challenges in diabetes management today
Tirzepatides dual action can cause more frequent gastrointestinal side effects (nausea and diarrhea)
20% higher D30 engagement from new features launched September 22, 2025 is based on a pre-post analysis from August 22 to October 24, 2025 of D30 engagement in key in-app behaviours (completing any Home Screen Task, tapping the Bank button to bank rewards for steps, viewing the Health Report, logging medication, or reading an article)